Macitentan for the Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension (Merit-1): Results from the Multicentre, Phase 2, Randomised, Double-Blind, Placebo-Controlled Study
The Lancet Respiratory Medicine(2024)
关键词
Treatment
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要